Sex as a predictor of response to cancer immunotherapy - Authors' reply.

Conforti, Fabio; Pala, Laura; Bagnardi, Vincenzo; De Pas, Tommaso; Marco, Martinetti; Viale, Giuseppe; Gelber, Richard; Goldhirsch, Aron

Conforti, Fabio; Pala, Laura; Bagnardi, Vincenzo; De Pas, Tommaso; Marco, Martinetti; Viale, Giuseppe; Gelber, Richard; Goldhirsch, Aron.

Afiliação

Conforti F; Division of Medical Oncology for Melanoma & Sarcoma, European Institute of Oncology, Milan 20141, Italy. Electronic address: fabio.conforti@ieo.it.
Pala L; Division of Medical Oncology for Melanoma & Sarcoma, European Institute of Oncology, Milan 20141, Italy.
Bagnardi V; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.
De Pas T; Division of Medical Oncology for Melanoma & Sarcoma, European Institute of Oncology, Milan 20141, Italy.
Marco M; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.
Viale G; Department of Pathology, European Institute of Oncology & State University of Milan, Milan, Italy.
Gelber R; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Frontier Science & Technology Research Foundation, Boston, MA, USA.
Goldhirsch A; Division of Medical Oncology for Melanoma & Sarcoma, European Institute of Oncology, Milan 20141, Italy.

Lancet Oncol ; 19(8): e380-e381, 2018 08.

Article em En | MEDLINE | ID: mdl-30102230

Assuntos

Neoplasias; Humanos; Imunoterapia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google